Entia Biosciences Company Description
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States.
The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases.
It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products.
In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites.
The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012.
Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.
| Country | United States |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Timothy Timmins |
Contact Details
Address: 13565 SW Tualatin-Sherwood Road Sherwood, Oregon 97140 United States | |
| Phone | 971-228-0709 |
Stock Details
| Ticker Symbol | ERGO |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US29481Q1094 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Timothy A. Timmins | Chief Executive Officer and President |
| Dr. Marvin S. Hausman M.D. | Chairman and Chief Science and Technology Officer |
| Elliot A. L. Shelton Esq. | Secretary and Director |